Pharma feed

N
Starbucks Corporation
Trade Arabia· 21 Jun 2021

Axiory launches exchange listed products account

Axiory Global, a leading trading solutions provider, has launched its new Axiory MT5 Alpha account, enabling investors to invest in some of the world’s biggest exchange-listed products, buying stocks and ETFs straight from their account. With the Axiory’s MT5 Alpha gives people access to invest in more than 100 global stocks and ETFs, including Apple, Netflix, Ford, Pfizer, Google, Amazon, McDonald’s, Tesla, Walt Disney, Starbucks, Microsoft, Garmin, Alibaba, eBay, Mastercard, and many more.

  • Starbucks Corporation
  • Pfizer Inc
  • Google Inc.
  • Alibaba
  • Apple Inc.
  • Netflix
  • MasterCard Inc
  • Microsoft Corporation
  • The Walt Disney Company
  • Garmin Ltd
  • New Offerings
  • News Articles
  • News Websites
N
NASCO
Biospectrum India· 21 Jun 2021

FICCI with Novartis, NASCO and GASCDO, host 2nd National Sickle Conclave

The conclave spearheaded discussions on the evolving SCD landscape, emerging therapies, and SCD care for women and children, including pregnancy and neonatal care FICCI, in collaboration with Novartis, National Alliance of Sickle Cell Organizations (NASCO) and Global Alliance of Sickle Cell Disease Organizations (GASCDO), recently held the 2nd National Sickle Cell Conclave on the occasion of World Sickle Cell Day.

  • NASCO
  • Novartis AG
  • Events
  • News Articles
  • News Websites
N
Pfizer Inc
The Economic Times· 21 Jun 2021

India in talks to find 'middle ground' with Pfizer, others for vaccine imports-Government official

India's government is in talks with Pfizer and other vaccine manufacturers for import of their COVID-19 vaccines in accordance with local laws, a senior government official said on Monday.

  • Pfizer Inc
  • Regulatory and Legal
  • News Articles
  • News Websites
N
GlaxoSmithKline PLC
Kam City· 21 Jun 2021

PharmaSGP Acquires Several OTC Brands From GSK

This website uses cookies to collect and analyse information on site performance and usage, customise advertisements, and allow you to access content. By continuing to use the website site you agree to our use of cookies. To find out more, visit the cookies section of our privacy policy here.

  • GlaxoSmithKline PLC
  • Regulatory and Legal
  • Divestiture
  • News Articles
  • News Websites
N
US Food and Drug Administration
Pharmaphorum· 21 Jun 2021

After FDA rejection, EU says yes to Sanofi's Aubagio in kids with MS -

Sanofi’s Aubagio has become the first oral therapy approved for first-line use in children and adolescents with multiple sclerosis in the EU, a few days after the same indication was turned down by the FDA in the US.

  • US Food and Drug Administration
  • Sanofi
  • Regulatory and Legal
  • News Articles
  • News Websites
N
Merck & Co., Inc.
Mirage News· 21 Jun 2021

New research shows Australian women with fertility problems would benefit from “back to basics” information

· Women are empowered by knowing when to seek help to conceive, how to follow medical advice and having balanced expectations · Merck launches ‘I Wish I’d Known’ online educational resources to answer core questions

  • Merck & Co., Inc.
  • New Offerings
  • News Articles
  • News Websites
N
Boehringer Ingelheim GmbH
Morningstar· 21 Jun 2021

Novartis, Bayer and Boehringer Ingelheim to showcase their commitment to a reimagined pharma industry

LONDON, June 21, 2021 /PRNewswire/ -- Board level executives from Novartis, Bayer and Boehringer Ingelheim, amongst many more, will showcase their long-term visions for healthcare as a response to the COVID-19 pandemic, by joining the speaker faculty at Reuters Events Pharma Europe 2021.

  • Boehringer Ingelheim GmbH
  • Reuters Events
  • Novartis AG
  • Bayer AG
  • Events
  • News Articles
  • News Websites
Pfizer Inc
Adamsmith· 21 Jun 2021

The difference between make and receive — Adam Smith Institute

We’re noting one of those little linguistic changes that are designed to deceive: Covid jabs for billions of humans will earn their makers billions of dollars The word “earn” usually means, with respect to corporate matters, the profit made, not the revenue: We look at the drug firms – led by Pfizer and Moderna – that are set to profit most in an unprecedented global vaccination drive The one thing the rest of the article does not even mention is profit.

  • Pfizer Inc
  • Financial Results
  • News Articles
  • Company Websites
N
Pfizer Inc
FiercePharma· 21 Jun 2021

Pfizer, Roche, Teva grab pharma Cannes Lions for 2021, but a wearable company scores the top creativity prize

Cannes Lions awarded its pharma Grand Prix—highly anticipated after last year’s festival cancellation—to a non-pharma company. Woojer audio wearable company, along with its health agency FCB Health’s Area 23, won the creativity festival's top pharma prize for “Sick Beats,” its music experience and treatment vest for people with cystic fibrosis.

  • FCB Health
  • Pfizer Inc
  • Cannes Lions International Festival
  • Awards and Recognitions
  • News Articles
  • News Websites
N
GlaxoSmithKline PLC
FiercePharma· 21 Jun 2021

Tension builds at GlaxoSmithKline as activist investor Elliott plots CEO Walmsley's removal, vaccine split: FT

Tension is building at GlaxoSmithKline in the run-up to a closely watched investor day scheduled for Wednesday. While CEO Emma Walmsley is slated to lay out her plan for a “new GSK,” her very position at the company may come under question.

  • GlaxoSmithKline PLC
  • Management Changes
  • News Articles
  • News Websites
N
Bayer AG
Morningstar· 21 Jun 2021

Bayer Files for U.S., EU Approval of Aliqopa/Rituximab Combo

By Colin Kellaher Bayer AG on Monday said it has filed for U.S. and European expanded approval of its cancer drug Aliqopa in combination with rituximab, a drug used to treat certain types of cancer and rheumatoid arthritis.

  • Bayer AG
  • Regulatory and Legal
  • News Articles
  • News Websites
N
Takeda Pharmaceutical Co Ltd
Mirage News· 21 Jun 2021

Draft Parkes Shire Housing Strategy now on exhibition

At the Ordinary Meeting of Council this week, Council resolved to endorse the Draft Parkes Shire Housing Strategy (2021-2041) for public exhibition. The Parkes Shire Housing Strategy sets a 20 year vision for housing in the Parkes Shire, in line with the NSW Government’s Local Housing Strategy Guideline and the Parkes Local Strategic Planning Statement (LSPS) 2041.

  • Takeda Pharmaceutical Co Ltd
  • Events
  • News Articles
  • News Websites
N
Bristol-Myers Squibb Co
Pharmaphorum· 21 Jun 2021

EU okays BMS' azacitidine pill for first-line maintenance of AML -

Bristol-Myers Squibb has been granted EU approval for Onureg (azacitidine), a tablet form of an intravenous drug that has been mainstay of acute myeloid leukaemia (AML) therapy for more than a decade. The EMA has cleared Onureg (formerly CC-486) as the first-ever orally-active drug that can be used for frontline maintenance treatment of AML who are in remission after initial chemotherapy but are not eligible for potentially curative therapies like a stem cell transplant.

  • Bristol-Myers Squibb Co
  • New Offerings
  • Regulatory and Legal
  • News Articles
  • News Websites
N
AstraZeneca PLC
FiercePharma· 21 Jun 2021

AstraZeneca, Novavax partner SK Bioscience eyes $132M vaccine production boost—and looks to add mRNA to the menu

COVID-19 production pacts have elevated the profile of numerous biopharmas during the pandemic, and that's certainly true for AstraZeneca and Novavax's partner SK Bioscience. The company is now channeling its recent momentum into a sizable manufacturing expansion at home.

  • Novavax Inc
  • AstraZeneca PLC
  • Business Expansion
  • News Articles
  • News Websites
N
Merck & Co., Inc.
Business Wire· 21 Jun 2021

Organon Announces Filing of Form 10-Q for the Quarter Ended March 31, 2021

Organon (NYSE: OGN) (the “company”), today announced that it has filed a Form 10-Q for the quarter ended March 31, 2021. In the filing, the condensed combined financial statements reflect the company’s financial position, results of operations and cash flows as it was operated as part of Merck prior to the spin-off, in conformity with U.S. generally accepted accounting principles ("GAAP").

  • Merck & Co., Inc.
  • Organon
  • Financial Results
  • Press Releases
  • Press Release Agencies
N
AstraZeneca PLC
Perth Now· 21 Jun 2021

Bruce Springsteen’s Broadway show reverses decision on fans vaccinated with AstraZeneca jab

All vaccinated Bruce Springsteen fans have been given the green light to attend his Broadway stage show after promoters last week said those given the AstraZeneca coronavirus jab would be turned away. Producers of the show Springsteen on Broadway — opening this weekend — last week said all audience members would need to be vaccinated with a US Food and Drug Administration-authorised vaccine (which excludes AstraZeneca).

  • AstraZeneca PLC
  • Events
  • News Articles
  • News Websites
N
AstraZeneca PLC
Bangkok Post· 21 Jun 2021

Ministry defends decision to grant ThaiBev jab support

Ministry defends decision to grant ThaiBev jab support People wait for their turn to receive the first dose of AstraZeneca vaccines at Thammasat University Hospital on Sunday. (Photo by Arnun Chonmahatrakool) Chatchai Promlert, permanent secretary for the Interior Ministry, is insisting that his approval to provide free Covid-19 vaccine doses to over 70,000 Thai Beverage Public Company Limited (ThaiBev) employees and their families is lawful.

  • AstraZeneca PLC
  • Thai Beverage PLC
  • Regulatory and Legal
  • News Articles
  • News Websites
N
Bayer AG
Morningstar· 21 Jun 2021

IBI-Ag Completes Funding Round for its New Class of Bioinsecticides

MISGAV, Israel, June 21, 2021 /PRNewswire/ -- IBI-Ag, a biotechnology company developing a new class of bioinsecticides, announced an investment round for the optimization of its first product and expansion of the product portfolio spectrum. Investors in the round include the Bayer-Trendlines Ag Innovation Fund, a partnership between The Trendlines Group and Bayer investing in breakthrough agricultural technologies, Agriline, and the Trendlines Group (SGX: 42T) (OTCQX: TRNLY).

  • Trendlines Group Ltd
  • Bayer AG
  • Funding Activities
  • News Articles
  • News Websites
N
Boehringer Ingelheim GmbH
Morningstar· 21 Jun 2021

Eli Lilly, Boehringer Ingelheim Get Europe OK for Jardiance in Systolic Heart Failure

By Colin Kellaher Eli Lilly & Co. and Boehringer Ingelheim on Monday said the European Commission approved the expanded use of their diabetes drug Jardiance as a treatment for adults with symptomatic chronic heart failure with reduced ejection fraction, also known as systolic heart failure.

  • Boehringer Ingelheim GmbH
  • Eli Lilly and Co
  • Regulatory and Legal
  • News Articles
  • News Websites
N
Takeda Pharmaceutical Co Ltd
Big News Network· 21 Jun 2021

Tigray Families Displaced by War, Economic and Social Crisis

SHIRE, ETHIOPIA - Hundreds of displaced families trampled down the stairs carrying stained mattresses, logs and kindling for cooking and sacks of clothing and food. The families, more than 5,000 people in all, had fled battles in the northern Tigray region to Shire, a historical commercial center.

  • Takeda Pharmaceutical Co Ltd
  • ESG
  • News Articles
  • News Websites
N
AstraZeneca PLC
Perth Now· 21 Jun 2021

James Merlino lashes vaccine rollout as ‘mess’ hours before national cabinet meets

The Acting Victorian Premier has labelled Australia’s vaccine rollout a “mess” and demanded the federal government accept vaccination as a race just hours before crunch talks with the Commonwealth. James Merlino made the comments ahead of emergency talks between state and territory leaders at a national cabinet meeting Monday to discuss damaging new medical advice on the AstraZeneca vaccine.

  • AstraZeneca PLC
  • Regulatory and Legal
  • News Articles
  • News Websites
N
Bayer AG
Youtube· 21 Jun 2021

Making, measuring, and maintaining a sustainable company

AboutPressCopyrightContact usCreatorsAdvertiseDevelopersTermsPrivacyPolicy & SafetyHow YouTube worksTest new features

  • Bayer AG
  • ESG
  • Videos
  • Social Media
N
Pfizer Inc
PR Newswire· 21 Jun 2021

Disruptive Floss Upgrade Provides Licensing Opportunity

AwesomeFloss.com's founder Leonard Lorch announced today that on June 10, 2021 he transmitted an invitation to Pfizer Inc's CEO Albert Bourla on Lorch's patented dental floss upgrade called the Awesome Floss® upgrade for Pfizer's joint venture with GSK pursuant to its JV's consumer products.

  • Pfizer Inc
  • Partnerships and Alliances
  • Press Releases
  • Press Release Agencies
N
Pfizer Inc
The Guardian· 21 Jun 2021

Coronavirus live news: US delays easing of land border restrictions; Japan to rule on allowing fans at Olympics

Reports suggest Tokyo 2020 organisers will allow 10,000 fans; New Zealand approves Pfizer vaccine for 12-15 year olds; US borders with Canada and Mexico to remain closed to non-essential travel until 21 July

  • Pfizer Inc
  • Regulatory and Legal
  • News Articles
  • News Websites
Novartis AG
Novartis AG· 21 Jun 2021

Discover how inflammation could fan the flames of cancer

Targeting inflammation to fight cancer is a new approach with a long history. Your body has a built-in sensor that self-assembles inside cells in response to a threat. This danger-sensing system is a large piece of cellular machinery, but until 20 years ago, no one knew it existed.

  • Novartis AG
  • New Offerings
  • Press Releases
  • Company Websites
1 2 3 4 5